Validation of biomarkers to predict response to immunotherapy in cancer: volume I—pre-analytical and analytical validation
GV Masucci, A Cesano, R Hawtin, S Janetzki… - … for immunotherapy of …, 2016 - Springer
Immunotherapies have emerged as one of the most promising approaches to treat patients
with cancer. Recently, there have been many clinical successes using checkpoint receptor …
with cancer. Recently, there have been many clinical successes using checkpoint receptor …
Evaluation of cellular immune response to adeno-associated virus-based gene therapy
B Gorovits, M Azadeh, G Buchlis, M Fiscella… - The AAPS journal, 2023 - Springer
The number of approved or investigational late phase viral vector gene therapies (GTx) has
been rapidly growing. The adeno-associated virus vector (AAV) technology continues to be …
been rapidly growing. The adeno-associated virus vector (AAV) technology continues to be …
A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma
PY Wen, DA Reardon, TS Armstrong… - Clinical Cancer …, 2019 - AACR
Purpose: To evaluate the results of the randomized, double-blind, placebo-controlled phase
II clinical trial of ICT-107 in patients with newly diagnosed glioblastoma. Patients and …
II clinical trial of ICT-107 in patients with newly diagnosed glioblastoma. Patients and …
FAP‐targeted photodynamic therapy mediated by ferritin nanoparticles elicits an immune response against cancer cells and cancer associated fibroblasts
S Zhou, Z Zhen, AV Paschall, L Xue… - Advanced functional …, 2021 - Wiley Online Library
Cancer‐associated fibroblasts (CAFs) are present in many types of tumors and play a pivotal
role in tumor progression and immunosuppression. Fibroblast‐activation protein (FAP) …
role in tumor progression and immunosuppression. Fibroblast‐activation protein (FAP) …
Guidelines for the automated evaluation of Elispot assays
S Janetzki, L Price, H Schroeder, CM Britten… - Nature protocols, 2015 - nature.com
The presented protocol for Elispot plate evaluation summarizes how to implement the
recommendations developed following the establishment of a large-scale international …
recommendations developed following the establishment of a large-scale international …
Assessing the Affinity Spectrum of the Antigen-Specific B Cell Repertoire via ImmunoSpot®
N Becza, Z Liu, J Chepke, XH Gao… - Handbook of ELISPOT …, 2024 - Springer
The affinity distribution of the antigen-specific memory B cell (Bmem) repertoire in the body
is a critical variable that defines an individual's ability to rapidly generate high-affinity …
is a critical variable that defines an individual's ability to rapidly generate high-affinity …
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification …
M Manak, L Gagnon, S Phay-Tran… - The Lancet …, 2024 - thelancet.com
Background Accurate quantitation of immune markers is crucial for ensuring reliable
assessment of vaccine efficacy against infectious diseases. This study was designed to …
assessment of vaccine efficacy against infectious diseases. This study was designed to …
[HTML][HTML] A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
EM Dijkgraaf, SJAM Santegoets, AKL Reyners… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Purpose Preclinical tumor models show that chemotherapy has immune modulatory
properties which can be exploited in the context of immunotherapy. The purpose of this …
properties which can be exploited in the context of immunotherapy. The purpose of this …
Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients
AE Snook, TR Baybutt, B Xiang, TS Abraham… - … for Immunotherapy of …, 2019 - Springer
Background The colorectal cancer antigen GUCY2C exhibits unique split tolerance, evoking
antigen-specific CD8+, but not CD4+, T-cell responses that deliver anti-tumor immunity …
antigen-specific CD8+, but not CD4+, T-cell responses that deliver anti-tumor immunity …
Photochemical internalization enhanced vaccination is safe, and gives promising cellular immune responses to an HPV peptide-based vaccine in a phase I clinical …
T Otterhaug, S Janetzki, MJP Welters… - Frontiers in …, 2021 - frontiersin.org
Background and Aims Photochemical internalization (PCI) is a technology for inducing
release of endocytosed antigens into the cell cytosol via a light-induced process. Preclinical …
release of endocytosed antigens into the cell cytosol via a light-induced process. Preclinical …